Healthy Technology Act of 2025

Hozzl · 2025-02-05T01:08:19Z

Explore the details of House Bill 238 Healthy Technology Act of 2025 currently in Congress. Get insights into its purpose, current status, sponsors, and potential impact on undefined. Stay informed on legislative developments.

2/5/2025, 1:08 AM

Summary of Bill HR 238

Bill 119 hr 238, also known as the "Artificial Intelligence and Machine Learning Practitioner Act," aims to amend the Federal Food, Drug, and Cosmetic Act to allow artificial intelligence and machine learning technologies to be recognized as practitioners eligible to prescribe drugs. This recognition would be contingent upon authorization by the relevant state and approval, clearance, or authorization by the Food and Drug Administration (FDA).

The bill seeks to clarify the legal status of artificial intelligence and machine learning technologies in the healthcare industry, specifically in the realm of prescribing medication. By allowing these technologies to be considered practitioners, the bill aims to streamline and enhance the prescription process, potentially improving patient care and outcomes.

In addition to addressing the role of artificial intelligence and machine learning technologies in prescribing medication, the bill also includes provisions for other purposes related to healthcare and technology. The overall goal of the bill is to modernize and update existing regulations to better accommodate the use of advanced technologies in the healthcare field. Overall, Bill 119 hr 238 represents a significant step towards integrating artificial intelligence and machine learning technologies into the healthcare system, with the potential to revolutionize the way medication is prescribed and administered.

Congressional Summary of HR 238

Healthy Technology Act of 2025

This bill establishes that artificial intelligence (AI) or machine learning technology may be eligible to prescribe drugs.

Currently, certain drugs may be dispensed only upon a prescription provided by a practitioner licensed by law to administer the drug. Under this bill, an AI or machine learning technology may qualify as such a prescribing practitioner if the technology is (1) authorized by state law to prescribe the drug involved; and (2) approved, cleared, or authorized under certain federal provisions pertaining to medical devices and products.

Read the Full Bill

Formatted Text PDF Formatted XML

Current Status of Bill HR 238

Bill HR 238 is currently in the status of Bill Introduced since January 7, 2025. Bill HR 238 was introduced during Congress 119 and was introduced to the House on January 7, 2025. Bill HR 238's most recent activity was Referred to the House Committee on Energy and Commerce. as of January 7, 2025

Bipartisan Support of Bill HR 238

Total Number of Sponsors

Democrat Sponsors

Republican Sponsors

Unaffiliated Sponsors

Total Number of Cosponsors

Democrat Cosponsors

Republican Cosponsors

Unaffiliated Cosponsors

Policy Area and Potential Impact of Bill HR 238

Primary Policy Focus

Alternate Title(s) of Bill HR 238

To amend the Federal Food, Drug, and Cosmetic Act to clarify that artificial intelligence and machine learning technologies can qualify as a practitioner eligible to prescribe drugs if authorized by the State involved and approved, cleared, or authorized by the Food and Drug Administration, and for other purposes.